114 related articles for article (PubMed ID: 12166507)
1. Survival of multiple sclerosis in Finland between 1964 and 1993.
Sumelahti ML; Tienari PJ; Wikström J; Salminen TM; Hakama M
Mult Scler; 2002 Aug; 8(4):350-5. PubMed ID: 12166507
[TBL] [Abstract][Full Text] [Related]
2. Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients.
Smestad C; Sandvik L; Celius EG
Mult Scler; 2009 Nov; 15(11):1263-70. PubMed ID: 19812114
[TBL] [Abstract][Full Text] [Related]
3. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada.
Kingwell E; van der Kop M; Zhao Y; Shirani A; Zhu F; Oger J; Tremlett H
J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):61-6. PubMed ID: 21865212
[TBL] [Abstract][Full Text] [Related]
4. Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study.
Lunde HMB; Assmus J; Myhr KM; Bø L; Grytten N
J Neurol Neurosurg Psychiatry; 2017 Aug; 88(8):621-625. PubMed ID: 28365589
[TBL] [Abstract][Full Text] [Related]
5. Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension.
Myhr KM; Riise T; Vedeler C; Nortvedt MW; Grønning R; Midgard R; Nyland HI
Mult Scler; 2001 Feb; 7(1):59-65. PubMed ID: 11321195
[TBL] [Abstract][Full Text] [Related]
6. Mortality and cause of death in multiple sclerosis: findings from a prospective population-based cohort in Bizkaia, Basque Country, Spain.
Rodríguez-Antigüedad Zarranz A; Mendibe Bilbao M; Llarena González C; Audicana C
Neuroepidemiology; 2014; 42(4):219-25. PubMed ID: 24821604
[TBL] [Abstract][Full Text] [Related]
7. Common comorbidities and survival in MS: Risk for stroke, type 1 diabetes and infections.
Murtonen A; Kurki S; Hänninen K; Soilu-Hänninen M; Sumelahti ML
Mult Scler Relat Disord; 2018 Jan; 19():109-114. PubMed ID: 29190573
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis survival: a population-based study in Sicily.
Ragonese P; Aridon P; Mazzola MA; Callari G; Palmeri B; Famoso G; Terruso V; Salemi G; D'Amelio M; Savettieri G
Eur J Neurol; 2010 Mar; 17(3):391-7. PubMed ID: 19863646
[TBL] [Abstract][Full Text] [Related]
9. Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway.
Grytten Torkildsen N; Lie SA; Aarseth JH; Nyland H; Myhr KM
Mult Scler; 2008 Nov; 14(9):1191-8. PubMed ID: 18632781
[TBL] [Abstract][Full Text] [Related]
10. Causes of death among patients with multiple sclerosis.
Sumelahti ML; Hakama M; Elovaara I; Pukkala E
Mult Scler; 2010 Dec; 16(12):1437-42. PubMed ID: 20826526
[TBL] [Abstract][Full Text] [Related]
11. Mortality in Hungarian patients with multiple sclerosis between 1993 and 2013.
Sandi D; Zsiros V; Füvesi J; Kincses ZT; Fricska-Nagy Z; Lencsés G; Vécsei L; Bencsik K
J Neurol Sci; 2016 Aug; 367():329-32. PubMed ID: 27423613
[TBL] [Abstract][Full Text] [Related]
12. [Survival in disseminated sclerosis in Denmark. A nation-wide study of the period 1948-1986].
Brønnum-Hansen H; Koch-Henriksen NJ; Hyllested K
Ugeskr Laeger; 1995 Dec; 157(51):7131-5. PubMed ID: 8545927
[TBL] [Abstract][Full Text] [Related]
13. Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland.
Phadke JG
J Neurol Neurosurg Psychiatry; 1987 May; 50(5):523-31. PubMed ID: 3495637
[TBL] [Abstract][Full Text] [Related]
14. Causes of death in patients with multiple sclerosis and matched referent subjects: a population-based cohort study.
Lalmohamed A; Bazelier MT; Van Staa TP; Uitdehaag BM; Leufkens HG; De Boer A; De Vries F
Eur J Neurol; 2012 Jul; 19(7):1007-14. PubMed ID: 22353360
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for survival in multiple sclerosis: a longitudinal, population based study in Møre and Romsdal, Norway.
Midgard R; Albrektsen G; Riise T; Kvåle G; Nyland H
J Neurol Neurosurg Psychiatry; 1995 Apr; 58(4):417-21. PubMed ID: 7738546
[TBL] [Abstract][Full Text] [Related]
16. Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study.
Leray E; Vukusic S; Debouverie M; Clanet M; Brochet B; de Sèze J; Zéphir H; Defer G; Lebrun-Frenay C; Moreau T; Clavelou P; Pelletier J; Berger E; Cabre P; Camdessanché JP; Kalson-Ray S; Confavreux C; Edan G
PLoS One; 2015; 10(7):e0132033. PubMed ID: 26148099
[TBL] [Abstract][Full Text] [Related]
17. A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy.
Skoog B; Runmarker B; Winblad S; Ekholm S; Andersen O
Brain; 2012 Mar; 135(Pt 3):900-11. PubMed ID: 22366800
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and disability progression in multiple sclerosis in Tunisia: do we really have a more aggressive disease course?
Sidhom Y; Damak M; Riahi A; Hizem Y; Mrissa R; Mhiri C; Gouider R
J Neurol Sci; 2014 Aug; 343(1-2):110-4. PubMed ID: 24980939
[TBL] [Abstract][Full Text] [Related]
19. Survival and cause of death in multiple sclerosis: a prospective population-based study.
Hirst C; Swingler R; Compston DA; Ben-Shlomo Y; Robertson NP
J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1016-21. PubMed ID: 18303108
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival of patients with multiple sclerosis in West France.
Leray E; Morrissey S; Yaouanq J; Coustans M; Le Page E; Chaperon J; Edan G
Mult Scler; 2007 Aug; 13(7):865-74. PubMed ID: 17881399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
